FDA targets barriers to generic competition

The Food and Drug Administration (FDA) has announced its intention to target the barriers to generic drug competition.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

USFDA to modernise generic review with $37.6m funding

19 June 2018 The US Food and Drug Administration is planning to use new budget funding to modernise generic drug review and promote more widespread use of generics.

Americas

FDA identifies companies ‘potentially blocking access’ to drug samples

21 May 2018 The US Food and Drug Administration has published a list of companies that it suspects might be preventing generic drug producers accessing samples of branded products.

Americas

FDA issues new guidance to boost generic competition

3 October 2017 The US Food and Drug Administration has issued new guidance as part of its bid to target the barriers to generic drug competition.